Trillium Health Partners
8
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
13%
1 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Keeping in Touch (KiT) With Youth as They Transition to Adult Type 1 Diabetes Care
Role: collaborator
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
Role: collaborator
Digital Bridge: Using Technology to Support Patient-centered Care Transitions From Hospital to Home
Role: collaborator
Oral Sodium Bicarbonate for the Prevention of Labour Dystocia
Role: collaborator
Evaluating the Effectiveness of the Nurse Ned Clinic
Role: collaborator
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
Role: collaborator
Care Transition Patient Experience Study With Electronic Tool
Role: lead
Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.
Role: collaborator
All 8 trials loaded